Advanced Search
Your search returned 206 results
  • Apr 25, 2014
    Net sales up 3% (up 4%, excluding foreign exchange rate movement)

    DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion...

  • Feb 27, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 27, 2014-- Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and...

  • Feb 27, 2014
    - U.S. revenue increased 94% in fourth quarter 2013 to $25.9 million, from $13.4 million in fourth quarter of 2012

    HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

  • Feb 18, 2014
    Revenue of $4.2 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...

  • Jan 27, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...

  • Jan 27, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...

  • Jan 24, 2014
    Net sales up 3% (up 5%, excluding foreign exchange rate movement); Medical Devices sales up 3% (up 6%, excluding foreign exchange rate movement)

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of

  • Jan 21, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to...

  • Jan 15, 2014

    DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

  • Jan 9, 2014
    New Therapeutic Device Company Launched by The Foundry

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...

  • Jan 6, 2014

    MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...

  • Sep 2, 2013

    Thomson Reuters ONE via COMTEX) --Medtronic Hospital Solutions Signs First Contracts with Two Leading Hospitals in Europe and Makes Equity Investment in NGC Medical MINNEAPOLIS AND TOLOCHENAZ -...

  • Aug 12, 2013

    Thomson Reuters ONE via COMTEX) --Cardiocom's Patient Management Offerings Reduce Healthcare Costs and Improve Care MINNEAPOLIS - August 12, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the...

  • Nov 20, 2012
    Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - November 20, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2013, which ended October 26, 2012. The Company reported...

  • Nov 1, 2012
    Accelerates Globalization and Company's Overall Position in Global Orthopedics Market

    MINNEAPOLIS, Nov. 1, 2012 - Medtronic, Inc. (NYSE: MDT) announced today that it has completed its acquisition of China Kanghui Holdings (NYSE: KH), a leading provider of orthopedic devices in...

  • Sep 27, 2012
    Acquisition Advances Medtronic's Globalization Strategy; Provides Strong Local China Operation as well as Broader Orthopedics Participation

    MINNEAPOLIS and CHANGZHOU, CHINA - Sept. 27, 2012 - Medtronic, Inc. (NYSE: MDT) and China Kanghui Holdings (NYSE: KH) announced today that they have entered into a merger agreement whereby...

  • Aug 21, 2012
    Revenue of $4.0 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - August 21, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2013, which ended July 27, 2012. The Company reported worldwide...

  • May 22, 2012
    Revenue of $4.3 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS--(BUSINESS WIRE)--May. 22, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 27, 2012. The company reported...

  • Feb 21, 2012
    Revenue of $3.9 Billion Driven by International Revenue Growth of 6% on a Constant Currency Basis, 7% as Reported

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2012, which ended January 27, 2012. The company...

  • Nov 20, 2011
    Revenue of $4.1 Billion Grew 3% on a Constant Currency Basis, 6% as Reported

    MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2012, which ended October 28, 2011. The company...

  • Nov 17, 2011

    MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE:MDT) and Bain Capital, a leading global private investment firm, today announced they have entered into a definitive...

  • Sep 27, 2011
    Study will evaluate new therapy option for patients suffering from valvular heart disease

    MINNEAPOLIS, Sep 27, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the start of the Engager(TM) European Pivotal Trial to pursue CE (Conformité Européenne) Mark for the...

  • Aug 31, 2011
    Medtronic Expands Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...

  • Aug 23, 2011
    Revenue of $4 Billion Driven by International Growth of 7% on a Constant Currency Basis; 19% as Reported

    MINNEAPOLIS, Aug 23, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011. The Company...

  • Jul 7, 2011
    Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...

  • Jul 7, 2011
    Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...

  • May 24, 2011
    Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%

    MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...

  • May 24, 2011

    MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...

  • Mar 14, 2011
    NewRemodeling Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

    MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour...

  • Feb 20, 2011
    Revenue of $4.0 Billion Grew 3% on Strength of New Products

    MINNEAPOLIS, Feb 22, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2011, which ended January 28, 2011. The company...

  • Jan 13, 2011
    Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation

    MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...

  • Nov 29, 2010
    International Revenue of $1.6 Billion Grew 6% on a Constant Currency Basis; 4% As Reported

    MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...

  • Nov 22, 2010

    MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...

  • Nov 18, 2010
    Tricuspid Annuloplasty Ring is Designed to Adapt to the Heart's Natural Tricuspid Valve Acquired Through ATS Medical, New Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

    MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch and first clinical use of the Tri-Ad(TM) Semi-Flexible Tricuspid Annuloplasty Ring for...

  • Nov 16, 2010
    Acquisition Expands Product Offering and Pipeline for Biologics Business

    MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...

  • Aug 24, 2010
    Updates Fiscal Year 2011 Revenue Outlook and EPS Guidance

    MINNEAPOLIS, Aug 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2011, which ended July 30, 2010. The company reported...

  • Aug 17, 2010
    Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business

    MEMPHIS, Tenn., Aug 17, 2010 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) and Osteotech, Inc., (NASDAQ: OSTE) today announced that the companies have signed a definitive agreement under which...

  • Aug 12, 2010

    MINNEAPOLIS, Aug 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed its acquisition of ATS Medical, Inc. following payment of $4.00 per share in cash for each...

  • Jun 23, 2010

    MINNEAPOLIS, Jun 23, 2010 (BUSINESS WIRE) --Gary Ellis, senior vice-president and chief financial officer at Medtronic, Inc. (NYSE: MDT) today reiterated fiscal year 2011 revenue and diluted...

  • May 25, 2010
    International Revenue Growth of 20 Percent

    MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...

  • May 20, 2010
    Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

    MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...

  • Apr 29, 2010
    Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease

    MINNEAPOLIS, Apr 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), and ATS Medical, Inc. (NASDAQ:ATSI), today announced that the companies have signed a definitive agreement under which...

  • Apr 21, 2010
    Acquisition Expands Product Offering and Pipeline for Cardiovascular Interventions

    MINNEAPOLIS, Apr 21, 2010 (BUSINESS WIRE) --Moving to expand its product offering,Medtronic, Inc. (NYSE: MDT), announced today that it has completed the acquisition of Invatec, a developer of...

  • Apr 21, 2010
    Now Indicated for Treatment of Peripheral Disease in the Iliac Arteries, Self-Expanding (SE) Device Redefines Deployment Accuracy for Precise Placement

    MINNEAPOLIS, Apr 21, 2010 (BUSINESS WIRE) --Broadening the scope of innovation for cardiovascular interventions beyond the heart, Medtronic, Inc. (NYSE: MDT), announced today that it has received...

  • Feb 23, 2010
    Non-GAAP diluted EPS of $0.77 grew 8%; GAAP diluted EPS of $0.75 grew 21%International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reportedFree cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billionWorldwide ICD revenue growth of 5% on a constant currency basis; 9% as reportedWorldwide CardioVascular revenue growth of 21% on a constant currency basis; 28% as reported

    MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010. The company...

  • Jan 25, 2010
    Acquisition Will Expand Product Offering and Pipeline for Cardiovascular Interventions

    MINNEAPOLIS, Jan 25, 2010 (BUSINESS WIRE) -- Moving to expand its impact on peripheral vascular disease,Medtronic, Inc. (NYSE:MDT), announced today that it has signed a definitive agreement to...

  • Nov 24, 2009
    Non-GAAP diluted EPS of $0.77 grew 15%; GAAP diluted EPS of $0.78 grew 63%

    MINNEAPOLIS--(BUSINESS WIRE)--Nov. 24, 2009-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009. The company...

  • Aug 22, 2006

    MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....

  • May 23, 2006

    MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...

  • Feb 21, 2006

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2006--Medtronic, Inc. (NYSE:MDT): -- Company-wide Revenue Increased 9% (Constant Currency Growth of 12%) -- Implantable Cardioverter Defibrillator (ICD)...

Show 5102550100 per page